Conflux两位创始人均为领航医药生物科技的执行董事

Blockbeats
01 Jul

BlockBeats 消息,7 月 1 日,据公开披露的资料显示,Conflux 的两位创始人龙凡及伍鸣,均为港股上市公司领航医药生物科技的执行董事。

目前领航医药生物科技公司总市值达 3.71 亿港元,约合 4726 万美元。Conflux(CFX)代币总市值达 3.93 亿美元,暂列加密货币市值排行榜第 138 位。

BlockBeats 此前报道,领航医药生物科技 (00399) 发布公告,于 2025 年 6 月 30 日,公司 (作为买方) 已与卖方 (Northwestern Foundation) 及 Conflux 订立谅解备忘录,内容有关收购目标公司全部股权的潜在收购事项,前提为目标公司按照与公司的协议完成收购 Conflux 资产。订立谅解备忘录表明公司致力透过潜在收购事项进军数码创新行业,以发展此新业务分部。公司认为此举不但可令集团业务更多元化,亦可为集团带来新溢利增长动力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10